Bank of America’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
JT
PA
BBA
OAG
Bank of America's PRAX Position: Q2 2026 in Review
Bank of America increased its Praxis Precision Medicines (PRAX) stake by 2.3% in Q2 2026, buying an estimated $3.9M and bringing the position to 546,930 shares worth $183M. The position accounts for 0.01% of the portfolio, ranked #825.
Bank of America first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Bank of America held 546,930 shares of Praxis Precision Medicines worth $183M as of Q2 2026.
- Bank of America bought 12,326 Praxis Precision Medicines shares in Q2 2026, an estimated $3.9M.
- Praxis Precision Medicines made up 0.01% of Bank of America's portfolio in Q2 2026, its #825 holding.
- Bank of America first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
- 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.